Peptide questions, checked carefully.Independent peptide information · Sources on every review · No sales · No dosing.

Claim being checked · Version 1 · Reviewed

“Selank has a proven safety profile in people.”

Written and source-checked by Anthony Treviso, founder of The Peptide Field.

No dosing advice. This guide explains research. It was not independently medically reviewed, and it does not diagnose, prescribe, or recommend treatment.

Not established. The reviewed evidence does not establish this statement. This does not prove it can never be true.

Answer scope

This verdict checks the exact claim in the heading. It is not a universal grade for Selank.

01 · Answer

Not established

The human studies were small and cannot show uncommon or long-term harms. FDA says important human safety information is missing for Selank acetate. For some ways of using it, FDA also warns of possible immune reactions from peptide clumps or related impurities.

What kind of evidence this is
No reliable human outcome evidence. No reliable study in people shows the health outcome in this statement.
What this answer covers
Long-term safety, uncommon harms, and the safety of each way it is used, chemical form, and finished product. This answer covers only the named molecule and finished product. It also covers the product form and how people used it. The study limits include who took part, what was used for comparison, what changed, and how long the study lasted.
Question type
Safety. What is known and not known about harm, warnings, and safety limits.

02 · Sources

Read the sources behind this answer

Editorial review
Internal editorial review recorded
Source review
Anthony Treviso · Founder and responsible editor
Medical review status
Not independently medically reviewed. Editorial source review does not replace medical review.